Back to Compound Explorer
Digoxin
Clinical trialMechanism of Action
Na+/K+-ATPase inhibition increasing intracellular calcium; positive inotropic effect; vagomimetic AV node effects
Research Notes
FoxgloveWestern
Digoxin is the FDA-approved cardiac glycoside for heart failure and atrial fibrillation with well-established pharmacokinetics. Increases cardiac contractility and slows AV node conduction. Primary active glycoside in Foxglove.
Found In 1 Herb
3D Molecular Structure
Cardiac glycoside
Drag to rotate · Click atoms to explore
Digoxin
Cardiac glycosideSugar-bound molecules that control drug release in the body
Representative pattern: C₁₁H₁₄O₆
Atoms
Carbon
Oxygen
Related Compounds (Cardiac glycoside)
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.